Authors:
Jeong, YY
Mitchell, DG
Hann, HWL
Malin, AK
Kang, HK
Holland, GA
Capizzi, RL
Citation: Yy. Jeong et al., Hepatocellular carcinoma after systemic chemotherapy: Gadolinium-enhanced MR measurement of necrosis by volume histogram, J COMPUT AS, 25(4), 2001, pp. 624-628
Citation: Rl. Capizzi et W. Oster, Chemoprotective and radioprotective effects of amifostine: An update of clinical trials, INT J HEMAT, 72(4), 2000, pp. 425-435
Citation: Rl. Capizzi, Recent developments and emerging options: The role of amifostine as a broad-spectrum cytoprotective agent - Introduction, SEMIN ONCOL, 26(2), 1999, pp. 1-2
Citation: Rl. Capizzi, The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine, SEMIN ONCOL, 26(2), 1999, pp. 3-21
Citation: Rl. Capizzi, Amifostine reduces the incidence of cumulative nephrotoxicity from cisplatin: Laboratory and clinical aspects, SEMIN ONCOL, 26(2), 1999, pp. 72-81
Authors:
Napoli, C
Salomone, S
Godfraind, T
Palinski, W
Capuzzi, DM
Palumbo, G
D'Armiento, FP
Donzelli, R
de Nigris, F
Capizzi, RL
Mancini, M
Gonnella, JS
Bianchi, A
Citation: C. Napoli et al., 1,4-dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive rats, STROKE, 30(9), 1999, pp. 1907-1915